Clinical Trial Update: A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

A Phase 1 study of RO6867461 in single- and multiple-ascending dose cohorts for wet age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• RO6867461

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED